Pegylated-interferon-alfa-2a

DRUG3 trials

Sponsors

Tibotec BVBA, Janssen-Cilag International NV

Conditions

Chronic Hepatitis CGenotype 1 Chronic Hepatitis CHepatitis C

Phase 2

An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection

CompletedNCT00580801

Tibotec BVBAHepatitis C

Start: 2008-01-31End: 2010-01-31Updated: 2013-09-09

Phase 3

Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C

CompletedNCT01498068

Janssen-Cilag International NVGenotype 1 Chronic Hepatitis C

Start: 2012-01-31End: 2013-03-31Updated: 2015-01-30

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

CompletedNCT01513941

Janssen-Cilag International NVChronic Hepatitis C

Start: 2012-04-30End: 2014-06-30Updated: 2016-05-05

Related Papers

Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study.

2015-10-192 citations

Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir.

2014-05-164 citations